Rose Wang, Founder and CEO of 1104 Health
Maryland-based health technology startup 1104Health has expanded its clinical network from 100 to more than 700 cancer care clinicians in 2026, marking a significant milestone in its effort to improve how cancer patients receive treatment across hospitals, health systems and medical practices.
Founded in 2022 by entrepreneur Rose Wang, the company is developing technology that connects community oncologists with specialists at major academic medical centers, enabling physicians to collaborate on treatment decisions, share clinical information and identify additional therapeutic options.
The company’s mission emerged from Wang’s personal experience navigating cancer treatment for her husband, Robert, who died on November 4 — the date that inspired the name 1104Health.
Turning Personal Loss Into Healthcare Innovation
When Robert was diagnosed with advanced cancer, Wang became his primary caregiver and patient advocate, coordinating treatment across three health systems and multiple physicians.
Despite access to highly qualified medical professionals, she encountered significant gaps in communication and coordination.
Seven months into his treatment, physicians informed the family that no further treatment options were available. Wang later learned that delays in coordinating care had contributed to Robert missing the eligibility window for a Phase 3 clinical trial.
The experience exposed what Wang saw as a systemic weakness in cancer treatment: physicians at different institutions often lack effective ways to collaborate, leaving patients and caregivers to navigate complex medical decisions.
Drawing on her background in computer science, software development, technology and clinical development strategy, Wang launched 1104Health to address those challenges.
Building a Connected Cancer Care Network
At the center of the company’s strategy is its Shared Care Network, a secure clinical collaboration platform designed to operate within existing electronic health record systems.
The platform aims to connect physicians across institutions, allowing community-based oncologists to consult specialists, coordinate treatment plans and identify clinical trials and emerging therapies that might otherwise be overlooked.
The approach is particularly relevant for patients receiving treatment outside major academic medical centers, where access to specialized expertise and clinical research opportunities may be more limited.
1104Health is also developing a compensation model that recognizes physicians for the time they spend collaborating on patient care.
By addressing both technological barriers and financial incentives, the company hopes to make coordination among cancer specialists a more routine and sustainable component of treatment.
Johns Hopkins, TEDCO Support Startup’s Development
Maryland’s life sciences and technology ecosystem has played an important role in 1104Health’s development.
The company co-developed and licensed its technology through Johns Hopkins Technology Ventures, leveraging the university’s research and commercialization infrastructure.
Additional support has included:
- Blackbird Laboratories: Funding support for the company’s initial pilot study.
- TEDCO: Entrepreneurial resources and assistance through Maryland’s technology development ecosystem.
- Maryland Innovation Initiative: Support for advancing research-based technology toward commercialization.
- $225,000 investment: Funding through TEDCO’s Social Impact Funds under the State Small Business Credit Initiative.
The combination of academic collaboration, early-stage financing and commercialization support has helped 1104Health advance its platform and expand its network of participating clinicians.
Clinical Network Grows More Than 600% in 2026
The company’s most significant reported milestone this year has been expanding its clinical network.
Beginning 2026 with approximately 100 cancer care clinicians, 1104Health increased participation to more than 700, representing growth of at least 600%.
The expansion provides a larger foundation for the company’s long-term objective of establishing a nationwide network connecting community physicians, cancer specialists and academic medical institutions.
Wang envisions a healthcare system in which access to specialized cancer expertise does not depend on a patient’s location, financial circumstances or ability to navigate multiple providers independently.
While the network’s growth demonstrates increasing clinician participation, the company has not disclosed corresponding figures for revenue, patient enrollment or clinical outcomes.
A Growing Opportunity in Cancer Care Technology
1104Health operates at the intersection of several important healthcare trends: digital health, clinical collaboration, precision oncology and efforts to improve access to cancer clinical trials.
As cancer treatments become increasingly specialized, coordination among oncologists, researchers and healthcare institutions is becoming more important.
For smaller oncology practices, consulting specialists at major medical centers could provide access to expertise that would otherwise require patients to travel or transfer care.
For academic medical centers, broader physician networks could potentially improve awareness of clinical trials and expand opportunities to identify eligible patients.
1104Health’s challenge will be translating its expanding clinician network into measurable improvements in care coordination, treatment access and patient outcomes.
For Wang, the mission remains personal: building a system that helps other families avoid the gaps in care she encountered during her husband’s illness.